UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000023120
Receipt No. R000026464
Scientific Title Open-label, dose-escalating clinical trial of Survivin-responsive conditionally replicative adenovirus (Surv.m-CRA-1) by local administration to evaluate the safety / tolerability and preliminary efficacy in patients with advanced solid tumors (Phase I trial).
Date of disclosure of the study information 2016/07/11
Last modified on 2019/11/09 18:59:01

No. Disposal Last modified on Item of update
1 Insert 2016/07/11 21:52:41
2 Update 2016/07/11 21:55:48 Date of disclosure of the study information
3 Update 2016/10/14 20:19:36 Recruitment status
4 Update 2017/02/21 18:05:28
5 Update 2017/03/06 20:16:57 Key inclusion criteria
Key inclusion criteria
6 Update 2017/03/06 20:17:43 Recruitment status
7 Update 2018/01/11 10:07:32 Recruitment status
8 Update 2018/09/03 21:35:07 Recruitment status
9 Update 2018/09/03 21:36:22 Last name of lead principal investigator
Last name of lead principal investigator
Email
10 Update 2019/04/22 21:27:26 Recruitment status
Date of IRB
Last follow-up date
11 Update 2019/11/09 18:59:01 Recruitment status


Contact us.